DiscoverLet’s Talk MedtechExploring FDA's Stance on LDTs & AI
Exploring FDA's Stance on LDTs & AI

Exploring FDA's Stance on LDTs & AI

Update: 2023-12-12
Share

Description

Benjamin Zegarelli, counsel with Mintz, gives some important regulatory updates surrounding laboratory-developed tests, artificial intelligence, and software. Oh yeah, we talk about a little thing called EU MDR in this new episode of Let's Talk Medtech.


Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Exploring FDA's Stance on LDTs & AI

Exploring FDA's Stance on LDTs & AI